Edition:
United States

Amyris Inc (AMRS.OQ)

AMRS.OQ on NASDAQ Stock Exchange Global Select Market

0.54USD
28 Apr 2017
Change (% chg)

$-0.01 (-1.62%)
Prev Close
$0.55
Open
$0.54
Day's High
$0.56
Day's Low
$0.53
Volume
762,995
Avg. Vol
593,721
52-wk High
$1.21
52-wk Low
$0.31

Latest Key Developments (Source: Significant Developments)

Amyris agrees to China manufacturing with Blue California
Tuesday, 18 Apr 2017 07:45am EDT 

April 18 (Reuters) - Amyris Inc :Amyris agrees to exclusive China manufacturing with Blue California enabling continued record product revenue growth into Asian markets.Amyris - agreement whereby affiliates will provide access to fermentation manufacturing in China, capital to produce no compromise ingredients for co.Amyris Inc - company expects to generate $50 million or more in revenue over next 12-18 months from its sales into China.  Full Article

Amyris updates on its liquidity needs
Monday, 17 Apr 2017 05:55pm EDT 

April 17 (Reuters) - Amyris Inc :Amyris Inc <<>> says it will likely need additional financing as early as the second quarter of 2017 to support its liquidity needs - SEC filing.Amyris Inc <<>> - If unable to raise additional financing, its ability to continue as a going concern would be jeopardized and may be unable to meet its obligations under existing debt facilities.  Full Article

Amyris says on Feb. 27, Co and Total Amyris Biosolutions B.V. entered into first amendment to research and development note
Friday, 3 Mar 2017 04:21pm EST 

Amyris Inc : Amyris inc- on february 27, 2017, company and total amyris biosolutions b.v. Entered into a first amendment to research and development note - sec filing .Amyris inc - pursuant to first amendment, parties agreed to extend maturity date of research and development note from march 1, 2017 to may 15, 2017.  Full Article

Amyris Q4 loss per share $0.14
Thursday, 2 Mar 2017 04:00pm EST 

Amyris Inc : Amyris more than doubles revenues over 2015 and provides strong growth outlook . Q4 revenue $32.2 million versus i/b/e/s view $38.7 million . Q4 loss per share $0.14 . Says sees more than doubling product revenues in 2017 while maintaining its strong performance in collaborations .Says 2017 growth outlook based on co's strong competitive position, currently contracted business and pipeline.  Full Article

Temasek Holdings reports 22.1 pct stake in Amyris as of Feb. 23
Monday, 27 Feb 2017 07:05am EST 

Amyris Inc : Temasek holdings (private) ltd reports 22.1 percent stake in amyris inc as of feb 23 - sec filing .Temasek holdings (private) ltd had reported a stake of 23.2 percent in amyris inc as of jan 6.  Full Article

Amyris says near-term debt maturities have been resolved
Friday, 3 Feb 2017 08:30am EST 

Amyris Inc : Amyris provides business update .Amyris Inc - near-term debt maturities have been resolved; completed strategic transition out of commodity products.  Full Article

Temasek Holdings Pvt Ltd reports 23.2 percent stake in Amyris Inc
Wednesday, 11 Jan 2017 09:34am EST 

Amyris Inc :Temasek Holdings (Private) Limited reports 23.2 percent stake in Amyris Inc as of January 6, 2017 versus 24.7 percent as of December 9,2016.  Full Article

Amyris files to say selling stockholder may offer 10 mln shares from time to time
Friday, 23 Dec 2016 05:34pm EST 

Amyris Inc :Files to say its selling stockholder may offer 10 million shares of co's common stock from time to time - SEC filing.  Full Article

Amyris Inc entered into securities purchase agreement relating to sale of a convertible note in original principal amount $10.0 million
Friday, 2 Dec 2016 04:44pm EST 

Amyris Inc : Amyris Inc says on Dec 1, entered into securities purchase agreement relating to sale of a convertible note in original principal amount $10.0 million .Amyris Inc says note convertible into shares of company s common stock at an initial conversion price of $1.90 per share.  Full Article

Amyris Inc signs multi-year collaboration extension with Kuraray
Thursday, 1 Dec 2016 08:30am EST 

Amyris Inc : Amyris signs multi-year collaboration extension with Kuraray .Amyris Inc - collaboration, features increased farnesene supply to Kuraray and joint marketing of products to industry and end-customers.  Full Article

More From Around the Web

BRIEF-Amyris agrees to China manufacturing with Blue California

* Amyris agrees to exclusive China manufacturing with Blue California enabling continued record product revenue growth into Asian markets